MedTrace Logo

Smoking Reduction and Cessation Interventions for Chinese

NCT00714532 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 298

Last updated 2013-07-10

No results posted yet for this study

Summary

This study aims at developing and testing a stage-based scheduled smoking intervention that targets to encourage smokers to reduce smoking and to facilitate smoking abstinence. We hypothesize that smokers who receive the staged-based scheduled smoking intervention will be more likely to report smoking abstinence, quit attempts, and smoking reduction at 12 months.

Conditions

  • Smoking Cessation

Interventions

BEHAVIORAL

Expert System Only

Expert system which includes a stage-matched manual, and a series of 3 individualized tailored feedback reports at baseline, 1, and 3 months

BEHAVIORAL

Enhanced Expert System

The intervention consists of 3 components: * Expert system which includes a stage-matched manual, and a series of 3 individualized tailored feedback reports at baseline, 1, and 3 months * scheduled smoking intervention, which includes a tailored-made 3-week smoking reduction schedule and a stage-matched tip guide to explain why and how to use the smoking reduction intervention * telephone check-in calls to provide brief counseling and technical support to motivate participants to use the intervention materials * a 2-week supply of nicotine gum or lozenge per participants' choice to use during smoking reduction

Sponsors & Collaborators

Principal Investigators

  • Janice Tsoh, PhD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00714532 on ClinicalTrials.gov